Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of Enapotamab Vedotin in solid tumors, including ovarian and cervical cancer; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer [Phase 3]
Phase 3 trial update on QL1706 combined with chemotherapy ± bevacizumab as first-line treatment for metastatic cervical cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab in metastatic or recurrent HPV-related cervical cancer has completed; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer [Phase 3]
Phase 3 trial comparing cisplatin and radiation with or without carboplatin and paclitaxel in locally advanced cervical cancer has completed…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 [Phase 3]
Phase III study comparing immunogenicity of a 9-valent HPV recombinant vaccine with Gardasil-9; status is UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India [Phase 4]
Phase 4 trial evaluating two versus three doses of an HPV vaccine in India for cervical cancer and precancerous lesions; status active not r…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas [NA]
Completed clinical trial evaluating multilevel interventions for self-screening in rural areas for colorectal and cervical cancer; results p…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA) [NA]
A completed clinical trial evaluating mHealth-supported Telecolposcopy for cervical cancer programs in low-resource settings, with results p…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer [Phase 2]
Phase 2 clinical trial update evaluating zimberelimab with concurrent radiotherapy and chemotherapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS withdrawal · 2022-10-05Clinical Trial Update: Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA) [Phase 3]
Phase 3 trial BRAVA comparing balstilimab to investigator’s choice chemotherapy in recurrent/metastatic cervical cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer [Phase 2]
Phase II trial evaluating the efficacy and safety of QL1706 in patients with cervical cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients [Phase 3]
Phase 3 trial updating adjuvant concurrent chemoradiotherapy versus radiotherapy in early-stage cervical cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial investigating pembrolizumab plus olaparib in recurrent cervical cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial [Phase 3]
Phase 3 trial evaluating integration of HPV vaccination and HPV-based cervical screening into ARV clinics (H2VICTORY).
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial update evaluating QL1706 plus chemotherapy with or without bevacizumab in first-line treatment for cervical cancer.
-
CLINICAL_TRIALS research · 2022-07-25Clinical Trial Update: Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix [NA]
A completed clinical trial evaluating high-resolution microendoscopy for adenocarcinoma in situ of the cervix.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 clinical trial exploring tislelizumab combined with bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical c…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]
Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase II study evaluating serplulimab plus bevacizumab with chemotherapy as first-line treatment for untreated recurrent or metastatic cervi…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors [Phase 2]
Phase 2 trial evaluating famitinib plus anti-PD1 therapy for advanced renal cell carcinoma, urothelial carcinoma, and gynecologic cancers su…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female [Phase 4]
Phase 4 trial update assessing lot consistency of recombinant HPV bivalent vaccine in healthy girls aged 9-14; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Trial to Optimally Show the Pharmacological Action of Z-100 [Phase 3]
Phase 3 trial assessing the pharmacological action of Z-100 for cervical cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Neoadjuvant Chemotherapy in Cervical Cancer [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemotherapy in cervical cancer has completed accrual and status is completed.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial [Phase 3]
A randomized Phase III trial comparing neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone for stage IIIC cervic…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy [Phase 2]
Phase 2 clinical study evaluating HLX10 with albumin-bound paclitaxel in advanced cervical cancer after progression or intolerance to first-…